Indegene Limited (NSE:INDGN)

Market Cap	137.54B
Revenue (ttm)	27.57B
Net Income (ttm)	3.84B
Shares Out	239.27M
EPS (ttm)	16.34
PE Ratio	35.18
Forward PE	29.02
Dividend	n/a
Ex-Dividend Date	n/a

Volume	265,651
Average Volume	424,085
Open	579.85
Previous Close	579.85
Day's Range	567.00 - 585.60
52-Week Range	470.10 - 736.30
Beta	n/a
RSI	54.87
Earnings Date	May 29, 2025

About Indegene

Indegene Limited operates as a life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, and Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platfor...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1998
• Employees: 4,367
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INDGN

Financial Performance

In 2023, Indegene's revenue was 25.90 billion, an increase of 12.29% compared to the previous year's 23.06 billion. Earnings were 3.37 billion, an increase of 26.53%.